We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bausch plus Lomb Corporation | NYSE:BLCO | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.95 | 0 | 09:00:00 |
Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of several scientific presentations and educational events during the European Dry Eye Society (EuDEC) 2024 Congress, which will take place in Madrid, Spain, June 20-22.
Data presentations highlight the results of several studies evaluating consumer, pharmaceutical and vision care products from the company’s broad eye care portfolio, in addition to evaluations of the dry eye treatment landscape and overall disease burden.
Educational sessions will feature innovations in clinical diagnosis and treatment of dry eye, including technological advancements.
The complete list of Bausch + Lomb scientific presentations as well as details for the featured education events is as follows:
Poster Presentations
Oral Presentation
Saturday, June 22
Featured Education Events
Saturday, June 22
About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.
© 2024 Bausch + Lomb. MTB.0240.USA.24
View source version on businesswire.com: https://www.businesswire.com/news/home/20240617086661/en/
Media Contact: Caryn Marshall caryn.marshall@bausch.com (908) 493-1381
Investor Contact: George Gadkowski george.gadkowski@bausch.com (877) 354-3705 (toll free) (908) 927-0735
1 Year Bausch plus Lomb Chart |
1 Month Bausch plus Lomb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions